日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Effectiveness of nirmatrelvir/ritonavir and molnupiravir on post-COVID diabetes risk among an older adult cohort: a target trial emulation study

尼马曲韦/利托那韦和莫努匹韦对老年人群新冠后糖尿病风险的影响:一项目标试验模拟研究

Guo, Zihao; Wei, Yuchen; Yang, Aimin; Wong, Carlos King Ho; Xiong, Xi; Wang, Kailu; Lin, Guozhang; Wang, Huwen; Hung, Chi Tim; Li, Conglu; Yam, Carrie Ho Kwan; Chow, Tsz Yu; Zhao, Shi; Mok, Chris Ka Pun; Hui, David S C; Yeoh, Eng Kiong; Chong, Ka Chun

Estimating the epidemic size of chikungunya virus infection in Guangzhou, China, from July to September 2025: a single-center cross-sectional study

估算2025年7月至9月中国广州基孔肯雅病毒感染的流行规模:一项单中心横断面研究

Lu, Weiguo; Guo, Zihao; Chong, Ka Chun; Huang, Junyuan; Chen, Chunke; Hui, David S; Zhao, Shi; Mok, Chris Ka Pun

Greater benefits of immediate nirmatrelvir-ritonavir initiation for post-COVID outcomes: a population-based retrospective cohort study

立即启动尼马曲韦-利托那韦治疗对新冠肺炎后预后更有益:一项基于人群的回顾性队列研究

Chong, Ka Chun; Wei, Yuchen; Wong, Carlos King Ho; Xiong, Xi; Wang, Huwen; Hung, Chi Tim; Li, Conglu; Yam, Carrie Ho Kwan; Chow, Tsz Yu; Guo, Zihao; Li, Kehang; Yang, Aimin; Mok, Chris Ka Pun; Hui, David S C; Zhao, Shi; Yeoh, Eng Kiong; Lin, Guozhang

HLA-B*15:01-positive severe COVID-19 patients lack CD8(+) T cell pools with highly expanded public clonotypes

HLA-B*15:01阳性的重症COVID-19患者缺乏具有高度扩增的公共克隆型的CD8(+) T细胞库

Rowntree, Louise C; Allen, Lilith F; Hagen, Ruth R; McQuilten, Hayley A; Quadeer, Ahmed A; Chaurasia, Priyanka; Kaewpreedee, Prathanporn; Lee, Kelly W K; Cohen, Carolyn A; Petersen, Jan; Littler, Dene R; Habel, Jennifer R; Zhang, Wuji; Cheng, Samuel M S; Chan, Ken Ka Pang; Kwok, Janette S Y; Leung, Kathy S M; Wu, Joseph T; Lee, Cheuk-Kwong; Davies, Jane; Pannaraj, Pia S; Kaity Allen, E; Thomas, Paul G; Tosif, Shidan; Crawford, Nigel W; Lappas, Martha; Thevarajan, Irani; Lewin, Sharon R; Kent, Stephen J; Juno, Jennifer A; Bond, Katherine A; Williamson, Deborah A; Holmes, Natasha E; Smibert, Olivia C; Gordon, Claire L; Trubiano, Jason A; Kotsimbos, Tom C; Cheng, Allen C; Efstathiou, Claudia; Turtle, Lance; Thwaites, Ryan S; Brightling, Christopher E; Rossjohn, Jamie; McKay, Matthew R; Tian, Jinmin; Liu, William Jun; Gao, George Fu; Xu, Jianqing; Sonehara, Kyuto; Ishii, Ken J; Namkoong, Ho; Okada, Yukinori; Peiris, Malik; Hui, David S C; Poon, Leo L M; Doherty, Peter C; Nguyen, Thi H O; Valkenburg, Sophie A; Kedzierska, Katherine

Effectiveness of nirmatrelvir/ritonavir and molnupiravir on post-COVID-19 outcomes among outpatients: a target trial emulation investigation

尼马曲韦/利托那韦和莫努匹韦对门诊COVID-19患者康复结局的疗效:一项目标试验模拟研究

Wei, Yuchen; Boyer, Christopher; Jia, Katherine Min; Lin, Guozhang; Wang, Huwen; Li, Conglu; Hung, Chi Tim; Jiang, Xiaoting; Yam, Carrie Ho Kwan; Chow, Tsz Yu; Wang, Yawen; Zhao, Shi; Guo, Zihao; Li, Kehang; Yang, Aimin; Mok, Chris Ka Pun; Hui, David S C; Chong, Ka Chun; Yeoh, Eng Kiong

Short- and long-term comparative effectiveness of nirmatrelvir/ritonavir and molnupiravir in asthma patients: a cohort study

尼马曲韦/利托那韦与莫努匹韦治疗哮喘患者的短期和长期疗效比较:一项队列研究

Lin, Guozhang; Wei, Yuchen; Guo, Zihao; Wang, Huwen; Chan, Kate Ching Ching; Chan, Renee Wan Yi; Hung, Chi Tim; Jiang, Xiaoting; Li, Conglu; Yam, Carrie Ho Kwan; Chow, Tsz Yu; Wang, Yawen; Zhao, Shi; Li, Kehang; Yang, Aimin; Mok, Chris Ka Pun; Hui, David S C; Yeoh, Eng Kiong; Chong, Ka Chun

Global perspectives on tuberculosis in prisons and incarceration centers - Risk factors, priority needs, challenges for control and the way forward

全球监狱和监禁中心结核病防治概览——风险因素、优先需求、防控挑战及未来发展方向

Nyasulu, Peter S; Hui, David S; Mwaba, Peter; Tamuzi, Jacques L; Sakala, Doris Y; Ntoumi, Francine; Maeurer, Markus; Goletti, Delia; Petersen, Eskild; Zumla, Alimuddin

Inequities underlie the alarming resurgence of Tuberculosis as the world's top cause of death from an Infectious Disease - Breaking the silence and addressing the underlying root causes

结核病再次成为全球传染病死亡首要原因,其背后隐藏着诸多不平等现象——打破沉默,直击根本原因。

Zumla, Alimuddin; Sahu, Suvanand; Ditiu, Lucica; Singh, Urvasha; Park, Young-Joon; Yeboah-Manu, Dorothy; Osei-Wusu, Stephen; Asogun, Danny; Nyasulu, Peter; Tembo, John; Kapata, Nathan; Alyaqoubi, Fatma; Maani, Amal Al; Blumberg, Lucille; Zumla, Adam; Ahmed, Rizwan; Go, Unyeong; Hui, David S; Goletti, Delia; Petersen, Eskild

Author Correction: Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population

作者更正:针对未感染过SARS-CoV-2病毒的人群中,针对Omicron BA.2变异株的真实世界COVID-19疫苗有效性

Lau, Jonathan J; Cheng, Samuel M S; Leung, Kathy; Lee, Cheuk Kwong; Hachim, Asmaa; Tsang, Leo C H; Yam, Kenny W H; Chaothai, Sara; Kwan, Kelvin K H; Chai, Zacary Y H; Lo, Tiffany H K; Mori, Masashi; Wu, Chao; Valkenburg, Sophie A; Amarasinghe, Gaya K; Lau, Eric H Y; Hui, David S C; Leung, Gabriel M; Peiris, Malik; Wu, Joseph T

SARS-CoV-2-specific CD8(+) T cells from people with long COVID establish and maintain effector phenotype and key TCR signatures over 2 years

来自新冠长期患者的 SARS-CoV-2 特异性 CD8(+) T 细胞可在 2 年内建立并维持效应表型和关键 TCR 特征。

Rowntree, Louise C; Audsley, Jennifer; Allen, Lilith F; McQuilten, Hayley A; Hagen, Ruth R; Chaurasia, Priyanka; Petersen, Jan; Littler, Dene R; Tan, Hyon-Xhi; Murdiyarso, Lydia; Habel, Jennifer R; Foo, Isabelle J H; Zhang, Wuji; Ten Berge, Elizabeth R V; Ganesh, Hanujah; Kaewpreedee, Prathanporn; Lee, Kelly W K; Cheng, Samuel M S; Kwok, Janette S Y; Jayasinghe, Dhilshan; Gras, Stephanie; Juno, Jennifer A; Wheatley, Adam K; Kent, Stephen J; Rossjohn, Jamie; Cheng, Allen C; Kotsimbos, Tom C; Trubiano, Jason A; Holmes, Natasha E; Pang Chan, Ken Ka; Hui, David S C; Peiris, Malik; Poon, Leo L M; Lewin, Sharon R; Doherty, Peter C; Thevarajan, Irani; Valkenburg, Sophie A; Kedzierska, Katherine; Nguyen, Thi H O